ES2158034T3 - Derivado de benzotiepina opticamente activo, su preparacion y uso. - Google Patents

Derivado de benzotiepina opticamente activo, su preparacion y uso.

Info

Publication number
ES2158034T3
ES2158034T3 ES95120444T ES95120444T ES2158034T3 ES 2158034 T3 ES2158034 T3 ES 2158034T3 ES 95120444 T ES95120444 T ES 95120444T ES 95120444 T ES95120444 T ES 95120444T ES 2158034 T3 ES2158034 T3 ES 2158034T3
Authority
ES
Spain
Prior art keywords
optically active
benzotiepine
derived
preparation
derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95120444T
Other languages
English (en)
Inventor
Takashi Sohda
Shigehisa Taketomi
Tsuneo Oda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Application granted granted Critical
Publication of ES2158034T3 publication Critical patent/ES2158034T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms
    • C07F9/655363—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms the sulfur atom being part of a six-membered ring
    • C07F9/655372—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms the sulfur atom being part of a six-membered ring condensed with carbocyclic rings or carbocyclic ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/67—Phosphorus compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6571—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
    • C07F9/657163—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms the ring phosphorus atom being bound to at least one carbon atom
    • C07F9/657181—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms the ring phosphorus atom being bound to at least one carbon atom the ring phosphorus atom and, at least, one ring oxygen atom being part of a (thio)phosphonic acid derivative

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

LA INVENCION SE REFIERE A UN DERIVADO DE LA BENZOTIEPINA, OPTICAMENTE ACTIVO REPRESENTADO POR LA FORMULA (I) EN DONDE R REPRESENTA UN GRUPO DE ALQUIL INFERIOR; R1 Y R2 REPRESENTAN INDEPENDIENTEMENTE UN GRUPO DE ALQUILO INFERIOR, O SE PUEDEN UNIR ENTRE SI PARA FORMAR UN ANILLO, EL DERIVADO EXHIBE UNA EXCELENTE ACCION PROMOTORA DE LAS OSTEOGENESIS Y UTIL COMO DROGA PROFILACTICA PARA ENFERMEDADES DE LOS HUESOS.
ES95120444T 1994-12-28 1995-12-22 Derivado de benzotiepina opticamente activo, su preparacion y uso. Expired - Lifetime ES2158034T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP32727594 1994-12-28

Publications (1)

Publication Number Publication Date
ES2158034T3 true ES2158034T3 (es) 2001-09-01

Family

ID=18197308

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95120444T Expired - Lifetime ES2158034T3 (es) 1994-12-28 1995-12-22 Derivado de benzotiepina opticamente activo, su preparacion y uso.

Country Status (20)

Country Link
US (2) US6346521B1 (es)
EP (1) EP0719782B1 (es)
KR (1) KR960022542A (es)
CN (1) CN1058718C (es)
AR (1) AR002018A1 (es)
AT (1) ATE202782T1 (es)
AU (1) AU689004B2 (es)
BR (1) BR9506098A (es)
CA (1) CA2166152A1 (es)
DE (1) DE69521595T2 (es)
DK (1) DK0719782T3 (es)
ES (1) ES2158034T3 (es)
FI (1) FI956273A (es)
GR (1) GR3036757T3 (es)
HU (1) HUT74562A (es)
NO (1) NO303641B1 (es)
NZ (1) NZ280745A (es)
PT (1) PT719782E (es)
RU (1) RU2162083C2 (es)
TW (1) TW403757B (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU717260B2 (en) * 1995-06-05 2000-03-23 Takeda Chemical Industries Ltd. Osteogenetic promoting pharmaceutical composition
US5910492A (en) * 1995-06-05 1999-06-08 Takeda Chemical Industries, Ltd. Osteogenic promoting pharmaceutical composition
CA2226317A1 (en) * 1995-07-24 1997-02-06 Takeda Chemical Industries, Ltd. Production of optically active benzothiepin salts
EP0949927B1 (en) * 1996-08-26 2002-10-16 Takeda Chemical Industries, Ltd. Pharmaceutical composition containing osteogenesis-promoting substance and a polyethylene glycol
EP0930874A2 (en) * 1996-10-09 1999-07-28 Takeda Chemical Industries, Ltd. A method for producing a microparticle
EP1087774A2 (en) * 1998-06-15 2001-04-04 Takeda Chemical Industries, Ltd. Compositions for treating cartilage disease comprising certain sulfur-containing heterocyclic compounds
WO2000008018A1 (fr) 1998-08-07 2000-02-17 Takeda Chemical Industries, Ltd. Derives de benzothiepine, leur procede de preparation et leurs utilisations
AR020158A1 (es) * 1998-08-12 2002-04-10 Takeda Chemical Industries Ltd Mejorador del factor de induccion para la diferenciacion celular
EP1120122A1 (en) * 1998-09-30 2001-08-01 Takeda Chemical Industries, Ltd. Bone repair materials/artificial bone compositions
JP2003528830A (ja) * 2000-03-10 2003-09-30 ファルマシア・コーポレーション テトラヒドロベンゾチエピン類の製造方法
EP1416919A1 (en) * 2001-07-17 2004-05-12 Teva Pharmaceutical Industries Ltd. Dosage forms for immediate gastric release of a calcium transport stimulator coupled with delayed gastric release of a bis-phosphonate
US20050026871A1 (en) * 2002-07-17 2005-02-03 Moshe Flashner-Barak Method of increasing bioavailability of alendronate or other bis-phosphonate by predose administration of vitamin D derivative
JPWO2005002590A1 (ja) * 2003-07-01 2006-08-10 アステラス製薬株式会社 骨量増加誘導剤
EP2160169A4 (en) * 2007-06-29 2017-07-05 KCI Licensing, Inc. Activation of bone and cartilage formation
JP5630868B2 (ja) 2009-01-19 2014-11-26 第一三共株式会社 ヘテロ原子を有する環状化合物
JP5698658B2 (ja) 2009-04-06 2015-04-08 第一三共株式会社 置換フェニル基を有する環状化合物
WO2011136264A1 (ja) 2010-04-28 2011-11-03 第一三共株式会社 ［５，６］複素環化合物
US10059663B2 (en) 2013-08-29 2018-08-28 Kyoto Pharmaceutical Industries, Ltd. Aromatic compound and use thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5158943A (en) * 1988-11-21 1992-10-27 Takeda Chemical Industries, Ltd. Sulfur-containing heterocyclic compounds
DK656789A (da) * 1988-12-28 1990-06-29 Takeda Chemical Industries Ltd Benzoheterocykliske forbindelser
DK0460488T3 (da) * 1990-05-30 2001-09-17 Takeda Chemical Industries Ltd Svovlholdige heterocykliske forbindelser
JP3165866B2 (ja) * 1990-06-06 2001-05-14 武田薬品工業株式会社 含硫黄複素環化合物

Also Published As

Publication number Publication date
TW403757B (en) 2000-09-01
GR3036757T3 (en) 2001-12-31
EP0719782B1 (en) 2001-07-04
CN1058718C (zh) 2000-11-22
DE69521595D1 (de) 2001-08-09
KR960022542A (ko) 1996-07-18
FI956273A0 (fi) 1995-12-27
NO955305D0 (no) 1995-12-27
CA2166152A1 (en) 1996-06-29
NO955305L (no) 1996-07-01
ATE202782T1 (de) 2001-07-15
FI956273A (fi) 1996-06-29
RU2162083C2 (ru) 2001-01-20
PT719782E (pt) 2001-10-31
HU9503802D0 (en) 1996-02-28
EP0719782A1 (en) 1996-07-03
AR002018A1 (es) 1998-01-07
NZ280745A (en) 1997-09-22
AU689004B2 (en) 1998-03-19
DK0719782T3 (da) 2001-09-24
AU4069395A (en) 1996-07-04
DE69521595T2 (de) 2002-05-23
US6632807B1 (en) 2003-10-14
HUT74562A (en) 1997-01-28
BR9506098A (pt) 1997-12-23
CN1131669A (zh) 1996-09-25
US6346521B1 (en) 2002-02-12
NO303641B1 (no) 1998-08-10

Similar Documents

Publication Publication Date Title
ES2158034T3 (es) Derivado de benzotiepina opticamente activo, su preparacion y uso.
ES2184070T3 (es) Derivados de oximas sustituidas utiles como antagonistas de la neuroquinina.
EA200702346A1 (ru) КРИСТАЛЛИЧЕСКАЯ ФОРМА 1-ХЛОР-4-(β-D-ГЛЮКОПИРАНОЗ-1-ИЛ)-2-[4-((S)-ТЕТРАГИДРОФУРАН-3-ИЛОКСИ)БЕНЗИЛ]БЕНЗОЛА, СПОСОБ ЕЁ ПОЛУЧЕНИЯ И ЕЁ ПРИМЕНЕНИЕ ДЛЯ ПРИГОТОВЛЕНИЯ ЛЕКАРСТВЕННЫХ СРЕДСТВ
BR0112756A (pt) Composto, composição farmacêutica, métodos para o tratamento de doenças mediadas por prostaglandina, de congestão nasal, asma alérgica, e rinite alérgica, e, uso de um composto
ES2192301T3 (es) Derivados de resorcinol.
ES2159491B1 (es) Base cristalina de citalopram
HN1999000124A (es) Derivados de pirazol substituido.
PA8577001A1 (es) Benzoilureas heterociclicamente sustituidas, procedimiento para su preparacion y su uso como farmacos
ES2112650T3 (es) Sales de un derivado de indol antimigraña.
DK1474406T3 (da) Disubstituerede thiazolylcarboxanilider samt deres anvendelse som mikrobicider
AR008861A1 (es) COMPUESTOS DE LACTAMA E IMIDA HETEROCICLICOS DE ARALQUILO Y ARALQUILEDENO, COMPUESTOS INTERMEDIARIOS PARA SU SíNTESIS, COMPOSICIONES FARMACÉUTICAS QUE LOS CONTIENEN.
CY1105301T1 (el) Αρυλοσυμπυκνωμενες αζαπολυκυκλικες ενωσεις
HN2004000538A (es) "PIRIDO[ 2,3-d ] PIRIMIDINA-2,4-DIAMINAS COMO-INHIBIDORES DE PDE 2"
PA8514401A1 (es) Nuevos derivados de piperazina
BR0207640A (pt) Composição farmacêutica oral de cefpodoxima proxetil
AR022469A1 (es) Uso de acidos isoxazolcarboxilicos sustituidos y derivados y nuevas sustancias
DK0929547T3 (da) Benzamidinderivater substitueret af cykliske aminosyrederivater eller cykliske hydroxysyrederivater og deres anvendelse som antikoagulantia
ES2055159T3 (es) Composiciones que inducen la union entre partes de tejido mineralizado vivo.
BR0015836A (pt) Cristal de 4-carboxiamino-2-etil-1,2,3,4-tetra-hidroquinolina como inibidor de cetp
DK1097173T3 (da) Anvendelse af peptider af IL-2 og derivater deraf som terapeutiske midler
UY27338A1 (es) Nuevos derivados de ácido sulfónico
SE9901077D0 (sv) Novel use
HN2002000365A (es) Lactamas como antagonistas de taquiquininas
EA200600605A1 (ru) Перегруппированные пентанолы, способ их получения и их применение в качестве противовоспалительных средств
HN2000000045A (es) Nuevas combinaciones farmaceuticas para inhibidores de la nos.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 719782

Country of ref document: ES